MarketScreener Strategies Plasmatech Biopharmaceuticals Inc Nasdaq
Equities
US72754H1095
End-of-day quote
Other stock markets
|
||
- USD | - |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
- Stock Market
- Equities
- ABEO Stock
- Stock
- News Plasmatech Biopharmaceuticals Inc
- MarketScreener Strategies